Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Exercise of warrants !!!!!!
View:
Post by stepbystep on Sep 16, 2016 6:41pm

Exercise of warrants !!!!!!

 
 
 
 
Latest 10 SEDI filings (by transaction date) for TST within the last 6 months ?
 Amended Filing
  As of 11:59pm ET September 15th, 2016
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 15/16 Sep 25/15 Rae, James Moodie Indirect Ownership Common Shares 54 - Exercise of warrants 50,000 $0.400
Sep 15/16 Sep 25/15 Rae, James Moodie Control or Direction Warrants  54 - Exercise of warrants -50,000 $0.400
Comment by rgonlyfactspls on Sep 16, 2016 11:13pm
Not sure why all the exclamation marks...but interesting to see an amended filing (yesterday) for a transaction that happened almost a year ago.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities